Pages
DCHS inclusion conference 2023
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/dchs-inclusion-conference-2023
Op COURAGE: The Veterans Mental Health and Wellbeing Service
https://dchs.nhs.uk/news/op-courage-veterans-mental-health-and-wellbeing-service
A peek into the future for Walton Hospital’s development
https://dchs.nhs.uk/news/peak-future-walton-hospitals-development
Bakewell’s new NHS health hub opening date confirmed for 23 September 2024
https://dchs.nhs.uk/news/bakewells-new-nhs-health-hub-opening-date-confirmed-23-september-2024
Belper’s new health centre – latest updates and project plans
https://dchs.nhs.uk/our-services-and-locations/our-locations/clinics-health-centres/belper-clinic
Files
Guidance for Wound Clinic Services for the use of tap water on chronic wounds (G308)
Guidance for Wound Clinic Services for the use of tap water on chronic wounds
L313 - Anticipatory Medicines and Syringe Drivers (Inpatients) Leaflet
L313 - Anticipatory Medicines and Syringe Drivers (Inpatients) Leaflet
ICS Catheter Clinic Guidance (G324)
ICS Catheter Clinic Guidance
Policy template FINAL (DCHS Policy Development Framework)
Policy template FINAL (DCHS Policy Development Framework)
Disclosure Ref 2024135 - No. of Datix Incidents Involving Patient Misidentification.pdf
FOI Disclosure Ref 2024135 regarding number of Datix Incidents Involving Patient Misidentification
Disclosure Ref 2024128 - Social Media Platforms.pdf
FOI Disclosure Ref 2024128 - Social Media Platforms
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates.pdf
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates
INR Testing procedure within Derbyshire Community Health Services by Podiatry Surgery at Ilkeston and Buxton Hospitals (S128)
Only podiatric surgery with the relevant equipment, training and framework in place will be able to utilise this procedure. This clinical procedure will support clinical staff in practice to include arrangements with regards the procedure of the taking of the INR test, quality assurance /quality control, Control of Substances Hazardous to Health (COSHH) assessment, Infection control measures, and any relevant Health and Safety issues. In line with recommendations within the Medicines and Healthcare Products Regulatory Agency (MHRA) Device Bulletin “Management and use of In Vitro Diagnostic (IVD) Point of Care Test Devices DB 2010(02) February 2010
A1 - Observational Audit - protected meal times (G50)
Observational Audit - protected meal times
Integrated Performance Report - November 2024
Integrated Performance Report - November 2024